Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 7/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | LPL | P06858 | 4/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29957011 | 1.00 | CA1 (0.38) | CA1CA2PDK2APEX1LPL | |
| SCHEMBL16633067 | 0.90 | PDK2 (0.37) | PDK2APEX1PGRCYP1A2CYP2C19 | |
| SCHEMBL3444144 | 0.88 | APEX1 (0.41) | CA1CA2PDK2APEX1LPL | |
| SCHEMBL16872804 | 0.85 | LIPG (0.40) | CA1CA2PDK2APEX1LPL | |
| SCHEMBL1453100 | 0.84 | PDK2 (0.36) | CA1CA2PDK2LPLLIPG | |
| SCHEMBL5502877 | 0.84 | LIPG (0.42) | CA1CA2PDK2APEX1LPL | |
| SCHEMBL5500164 | 0.83 | APEX1 (0.38) | CA1CA2PDK2APEX1PGR | |
| SCHEMBL5502876 | 0.83 | PDK2 (0.34) | CA1CA2PDK2APEX1LPL | |
| SCHEMBL5497942 | 0.83 | PDK2 (0.34) | CA1CA2PDK2APEX1LPL | |
| SCHEMBL6234954 | 0.83 | LIPG (0.43) | CA1CA2PDK2APEX1LPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111825722-A | Saturated red luminescent fluorenyl benzoquinoline iridium complex | 北京印刷学院 | 2020-10-27 | — | — | CN | claimed |
| CN-111825722-B | Saturated red-light-emitting fluorenyl benzoquinoline iridium complex | 北京印刷学院 | 2023-06-09 | — | — | CN | disclosed |
| CN-108822550-B | Preparation method of novel liquid crystal elastomer material | 浙江鑫都文化用品股份有限公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-111825722-A | Saturated red luminescent fluorenyl benzoquinoline iridium complex | 北京印刷学院 | 2020-10-27 | — | — | CN | disclosed |
| US-20180141957-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-8084937-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
| CN-100427467-C | Compound, organic light emitting diode comprising compound and display | YOUDA PHOTOELECTRIC CO LTD (CN) | 2008-10-22 | — | — | CN | disclosed |
| CN-1657588-A | Compound, organic light emitting diode comprising compound and display | YOUDA PHOTOELECTRIC CO LTD (CN) | 2005-08-24 | — | — | CN | disclosed |
| US-6921915-B2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2005-07-26 | — | — | US | disclosed |
| EP-1238981-B1 | Metal coordination compound, luminescence device and display apparatus | CANON KK (JP) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004053018-A1 | ELECTROLUMINESCENT DEVICES | XIE SHUANG (CA) | 2004-06-24 | — | — | WO | disclosed |
| US-20030215667-A1 | Electroluminescent devices | ELIGHT CORPORATION (VG) | 2003-11-20 | — | — | US | disclosed |
| US-20030068535-A1 | Metal coordination compound, luminescence device and display apparatus | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2003-04-10 | — | — | US | disclosed |
| EP-1238981-A2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030068535-A1 | Metal coordination compound, luminescence device and display apparatus | CCNL2, CYC1, CYCS | CA1 1388/4885CA2 919/4885PDK2 1769/4885 |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | ALPL, MT-ND4L, LAGE3 | CA1 1619/4885CA2 2974/4885PDK2 2968/4885 |
| US-20180141957-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | CA1 1041/4885CA2 1260/4885PDK2 2702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.